Physician

Cody Milliman

According to 2025 Medicare claims, Cody Milliman (NPI: 1730615980) practices internal medicine in the Baton Rouge, LA market, with the plurality of this provider's patient population coming from E. Baton Rouge, LA. This provider's primary affiliated billing organization is MARY BIRD PERKINS CANCER CENTER (NPI: 1295833580; TIN: 237010520) and primary practice location at 70809-3482.

Milliman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 249 traditional Medicare patients, billed 53,921 HCPCS/CPT codes, and received $1,331,946 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,098 prescription claims across 150 beneficiaries totaling $3,326,891 in drug costs, led by Pomalyst (Pomalidomide). 2019 DME data shows 23 claims. Open Payments data shows 117 records totaling $2,354. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,511 and ending at $3,326,891. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$666K$1.3M2023 Medicare payment: $11,764 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,331,946 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202327100$11,764
202424953,921$1,331,946

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.3M2017 Drug cost: $1,511 (USD; Tot_Drug_Cst)2018 Drug cost: $2,787 (USD; Tot_Drug_Cst)2019 Drug cost: $237 (USD; Tot_Drug_Cst)2020 Drug cost: $1,117 (USD; Tot_Drug_Cst)2021 Drug cost: $200 (USD; Tot_Drug_Cst)2023 Drug cost: $73,180 (USD; Tot_Drug_Cst)2024 Drug cost: $3,326,891 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R27$1,511
20181440$2,787
2019N/R11$237
20201425$1,117
2021N/R13$200
2022N/RN/RN/R
20232876$73,180
20241501,098$3,326,891

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$723$1.4K2019 Medicare payment: $1,447 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R23$1,447
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more2929$159
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more168451$129
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more101176$92
96413Administration of chemotherapy into vein, 1 hour or less27139$90
96375Injection of additional new drug or substance into vein33169$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide35980$883,860
Abiraterone AcetateAbiraterone Acetate1073,450$469,201
RevlimidLenalidomide22616$463,739
XtandiEnzalutamide21630$301,960
ImbruvicaIbrutinib16460$256,637

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.117$2,354PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Cody Milliman?

Tedicare shows public-source Medicare data for Cody Milliman (NPI 1730615980), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cody Milliman have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Cody Milliman?

Cody Milliman is linked to MARY BIRD PERKINS CANCER CENTER (billing NPI 1295833580) in the available physician profile data.

Does Cody Milliman have Open Payments data?

Cody Milliman has 117 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.